KLEON TSETIS FOUNDATION

research

innovative thinking

innovation

science

generosity

humanity

research

innovative thinking

innovation

science

generosity

humanity

research

innovative thinking

innovation

science

generosity

humanity

research

innovative thinking

innovation

science

generosity

humanity

In honor of Kleon Tsetis, the founder of the Tsetis Pharmaceutical Group of Companies, his daughters and successors, Julia and Irene Tsetis, established the KLEON TSETIS Non-Profit Civil Company (NPCC) for Scientific Research and Culture in November 2017, drawing inspiration from the values and principles he instilled in the Group from its inception.

Vision & Mission

The KLEON TSETIS NPCC was founded with the mission to support and enhance creative thinking, scientific research, and continuous progress. With a vision to improve health and quality of life, it serves science, education, the arts, and innovation—providing growth opportunities for the new generation of scientists and strengthening synergies between Academic Institutions, Research Centers, and Industry.

The Main Actions of KLEON TSETIS NPCC:

Supporting Young Scientists & Reversing Brain-Drain
Supporting Universities & Research Institutions
Bridging Industry & Academia

KLEON TSETIS NPCC: A beacon of research, innovation, and contribution

History

The restless scientist, distinguished pharmacist, and pioneering industrialist shaped his era through his creative spirit, innovative thinking, and profound sense of social responsibility. His vision transcended the boundaries of his time, giving substance to the concepts of scientific progress and business ethics.

His impact remains indelible, not only within the Greek pharmaceutical industry but also across society, as his values and actions laid the foundation for the institution that proudly bears his name today.

and thus, "Apeirotan" was born

Kleon Tsetis—the restless pharmacist and researcher who tirelessly studied the bioequivalence of medicines, the relentless industrialist, and the compassionate citizen—inspired the creation of an institution bearing the emblematic message "Apeirotan."

Research activity

The establishment of synergies between industry and the academic community, the consistent support of research activities and young scientists, as well as the promotion of innovation, constitute key priorities for both OFET and the KLEON TSETIS NPCC.

The Tsetis Pharmaceutical Group of Companies (OFET) has established a broad scientific network, consisting of more than 30 research teams, strengthening the connection of researchers across all fields of Health Sciences with the academic community throughout Greece.

ACTIONS & DONATIONS

Since its establishment in 2017, the KLEON TSETIS NPCC has actively supported 30 outstanding students and researchers through scholarships, and 26 scientific and research programs by providing grants for consumables and essential equipment.